Prelude Therapeutics Incorporated · NASDAQ:PRLD
Ra Capital Management, L.P. reported a 9.90% stake in Prelude Therapeutics Incorporated (Schedule 13G)
Event Apr 21, 2026 · Filed Apr 28, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Prelude Therapeutics Incorporated, 6,477,309 shares, as a passive investor on Apr 21, 2026. Filed Apr 28, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 6,477,309
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 6,477,309 |
| Peter Kolchinsky | 9.90% | 6,477,309 |
| Rajeev Shah | 9.90% | 6,477,309 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 6,477,309 |
Source
Related
- Prelude Therapeutics Incorporated
- Ra Capital Management, L.P.
- Prelude Therapeutics Incorporated shareholders
- Schedule 13G · Soleus Capital Management, L.P. · Jul 8, 2026
- Form 4 · Shah Rajeev M. · Apr 28, 2026
- Form 4 · Bonita David P · Apr 23, 2026
- Form 4 · OrbiMed Genesis GP LLC · Apr 23, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Apr 23, 2026